The amino acid L-serine shows efficacy in treating patients with mutations in GRIN genes

by Fundació Clínic per a la Recerca Biomèdica

A clinical trial has demonstrated the potential of the amino acid L-serine, administered as an oral supplement, to improve the function of glutamate receptors in patients with GRINpathies.

Read more

Doctors from the Hospital Clínic-IDIBAPS authors of an article proposing possible population screening strategies for liver fibrosis

by Fundació Clínic per a la Recerca Biomèdica

A team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded through the Horizon 2020 programme, used their expertise and all they learnt in the colorectal and lung cancer scr...

Read more

Changes in the immune system response play a key role in the progression of pulmonary fibrosis

by Fundació Clínic per a la Recerca Biomèdica

Researchers at the Hospital Clínic-IDIBAPS have assessed the role of the immune system in patients with idiopathic pulmonary fibrosis (IPF) through three studies.

Read more

El Clínic, primer hospital de España en extirpar tumores del oído medio a través de cirugía endoscópica

by Fundació Clínic per a la Recerca Biomèdica

Un estudio demuestra que esta técnica mínimamente invasiva es segura y eficaz en la fase inicial de tumores del oído medio, y que disminuye el tiempo de hospitalización de los pacientes.

Read more

A European project led by IDIBAPS wants to advance precise spatiotemporal control of brain activity for therapeutic purposes

by Fundació Clínic per a la Recerca Biomèdica

Funded by the European Union, META-BRAIN project presents an innovative approach to controlling brain activity by means of nanotechnology, with reduced magnetic field requirements, wireless capability...

Read more

The Hospital Clínic-IDIBAPS leads the largest European study to date on liver disease

by Fundació Clínic per a la Recerca Biomèdica

The project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow liver disease to be detected in the earliest stages, an...

Read more

Hospital Clínic-IDIBAPS researchers review adjuvant treatment with immunotherapy and vaccines for liver cancer

by Fundació Clínic per a la Recerca Biomèdica

The combination of surgery with adjuvant immunotherapy, after surgery, was shown to improve disease-free survival rates in the last IMbrave 050 phase III study

Read more

A European study in people with the participation of Clínic-IDIBAPS shows that treatment with the drug Abatacept reduces the risk of developing rheumatoid arthritis

by Fundació Clínic per a la Recerca Biomèdica

Published in the journal The Lancet, the study presents the results of Abatacept, a drug that modulates the activation of T cells, which play a key role in the progression of the disease.

Read more

A European project led by IDIBAPS will test a diagnostic genomic test for breast cancer to improve patients' quality of life

by Fundació Clínic per a la Recerca Biomèdica

The DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX® improves quality of lif...

Read more

The PEACHD European project is launched to improve cancer prevention in specific vulnerable groups in Europe

by Fundació Clínic per a la Recerca Biomèdica

Endowed with 1.25 million euros, the project is coordinated by IDIBAPS’ Clinical Addictions Research Group (GRAC-GRE), which is led by Hugo López-Pelayo, a researcher and medical specialist at Hosp...

Read more

Clínic-IDIBAPS researchers detect an increase in mental health problems among female adolescents after lockdown

by Fundació Clínic per a la Recerca Biomèdica

The study shows an upward trend in emergency admissions related to eating disorders, self-harm and suicide ideation and attempts, particularly among female adolescents.

Read more

Presentation of the first model to predict response to CAR T-cell therapy in multiple myeloma

by Fundació Clínic per a la Recerca Biomèdica

An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer after CAR T-cell therapy.

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Combination of fasting and chemotherapy ...

by CNIO - Centro Nacional de Investigaciones Oncológicas

New study reveals that the positive effect of combining fasting and ch...

Photos Stream